Children and young people are increasingly likely to receive information regarding inherited
health risks relevant to their genetic relatives and themselves. We reviewed the literature to …

A simple tactic for electrochemical determination of a typical biomarker for breast cancer,
human epidermal growth factor receptor 2 (HER2), was presented via the construction of a …

Genetic testing is becoming increasingly available for adolescents who are undergoing
cancer treatment or at risk of cancer predisposition syndromes. With this narrative review, we …

While family communication about a BRCA1 or BRCA2 (BRCA1/2) pathogenic variant can
be a catalyst for the uptake of risk‐reducing measures in young adults, disseminating …

Whether children should be offered genetic testing for cancer risk is much debated but
young voices are rarely heard in these conversations. The current study explored …

Young women from hereditary breast and ovarian cancer (HBOC) families face a series of
medical decisions regarding their cancer risk management and integrating this information …

Purpose: Li-Fraumeni syndrome (LFS), a multiorgan cancer predisposition caused by
germline TP53 mutations, confers significant cancer risks for young people (15–39 years) …

Purpose To evaluate the impact of breast cancer family history and maternal BRCA1/2
mutation on the psychosocial adjustment and perceived risk in girls age 11 to 19 years old …

Background: Although the timing of pubertal milestones has been associated with breast
cancer risk, few studies of girls' development include girls at increased breast cancer risk …

OBJECTIVE: Understanding how young girls respond to growing up with breast cancer
family histories is critical given expansion of genetic testing and breast cancer messaging …